A new publication has been released this summer in Metabolomics.
Entitled “Metabolomics, lipidomics and proteomics profiling of myoblasts infected with Trypanosoma cruzi after treatment with different drugs against Chagas disease”, it is the result of a collaboration between BIOASTER, the Drugs for Neglected Diseases Initiative (DNDi) and the London School of Hygiene and Tropical Medicine and leverage BIOASTER’s Omics technologies to address the discovery of new drugs against the Chagas disease.
Get the paper here:
https://rdcu.be/bPlfy